ライフサイエンスコーパス: erythromycin A

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 g the acid-catalyzed degradation reaction of erythromycin A.

2 was not detected in controls with or without erythromycin A.

3 acid stability of erythromycin B relative to erythromycin A.

4 to children as a suspension of the pro-drug erythromycin A 2'-ethyl succinate.

5 cursor-directed biosynthesis of 15-propargyl erythromycin A, a novel antibiotic that not only is as p

6 ae, as well as improved activity compared to erythromycin A against the inducibly MLS (macrolide, lin

7 -dihydro-9-acetamido-N-desmethyl-N-isopropyl erythromycin A analogues and related derivatives was gen

8 The macrolide antibiotic erythromycin A and its semisynthetic analogues have been

9 zed hydrolysis of the 2'-ethyl succinates of erythromycins A and B.

10 Antibiotics such as doxycycline and erythromycin A are no exception.

11 ndustrial-scale production of the antibiotic erythromycin A, derivatives of which play a vital role i

12 In the presence of cytomix, erythromycin A did not decrease NO, nitrite, iNOS protei

13 e is much more stable than the corresponding erythromycin A ester, degrading nearly 40 times more slo

14 The antibiotic erythromycin A is generally administered to children as

15 Erythromycin A is normally formulated for children as it

16 Three polyketide natural products, namely erythromycin A, lasalocid A, and iso-lasalocid A, were s

17 l drugs--norfloxacin, a fluoroquinolone, and erythromycin, a macrolide--proteins with single mutation

18 Erythromycin, a non-peptide motilin receptor agonist, in

19 epithelial cells, effects of doxycycline and erythromycin A on inducible NO synthase (iNOS) NO produc

20 We compared CYP3A metabolism of erythromycin (a Pgp substrate) using the erythromycin br

21 Erythromycin, a potent inhibitor of bacterial and mitoch

22 any link between this and the modulation of erythromycin A titre, which has been observed for S. ery

23 At 0.5 microg/ml erythromycin, a total of eight strains (four Campylobact

24 e the extent of CYP3A-mediated metabolism of erythromycin, a widely used model substrate for CYP3A.

25 vel antibiotic that not only is as potent as erythromycin A with respect to its ability to inhibit ba

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。